2-Phenylindole sulfamates: Inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 88, Issue 4-5, 2004, Pages 409-420

  Walter, Georg ^a   Liebl, Renate ^a   Von Angerer, Erwin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Breast cancer; Enzyme inhibition; Phenylindole sulfamate; Steroid sulfatase

Indexed keywords

2 PHENYLINDOLE SULFAMATE; ENZYME INHIBITOR; ESTRONE SULFATE; INDOLE DERIVATIVE; STERYL SULFATASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; ENZYME INHIBITION; ESTROGEN ACTIVITY; GENE ACTIVATION; HUMAN; HUMAN CELL; HYDROLYSIS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; ENZYME INHIBITORS; ESTRONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROLYSIS; HYDROPHOBICITY; INHIBITORY CONCENTRATION 50; RECEPTORS, ESTROGEN; STERYL-SULFATASE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 2442563905     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2003.12.012     Document Type: Article

References (47)

1. Chetrite G.S., Cortes-Prieto J., Philippe J.C., Wright F., Pasqualini J.R. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J. Steroid Biochem. Mol. Biol. 72:2000;23-27
2. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 81:1996;1460-1464
3. Evans T.R., Rowlands M.G., Silva M.C., Law M., Coombes R.C. Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer. J. Steroid Biochem. Mol. Biol. 44:1993;583-587
4. Pasqualini J.R., Chetrite G., Nguyen B.L., Maloche C., Delalonde L., Talbi M., Feinstein M.C., Blacker C., Botella J., Paris J. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J. Steroid Biochem. Mol. Biol. 53:1995;407-412
5. Luu-The V. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 76:2001;143-151
6. Breitling R., Krazeisen A., Moller G., Adamski J. 17β-Hydroxysteroid dehydrogenase type 7- an ancient 3-ketosteroid reductase of cholesterogenesis. Mol. Cell Endocrinol. 171:2001;199-204
7. Gunnarsson C., Ahnstrom M., Kirschner K., Olsson B., Nordenskjold B., Rutqvist L.E., Skoog L., Stal O. Amplification of HSD17B1 and ERBB2 in primary breast cancer. Oncogene. 22:2003;34-40
8. Gunnarsson C., Olsson B.M., Stal O. Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence. Cancer Res. 61:2001;8448-8451
9. Chetrite G.S., Pasqualini J.R. The selective estrogen enzyme modulator (SEEM) in breast cancer. J. Steroid Biochem. Mol. Biol. 76:2001;95-104
10. Utsumi T., Yoshimura N., Takeuchi S., Maruta M., Maeda K., Harada N. Elevated steroid sulfatase expression in breast cancers. J. Steroid Biochem. Mol. Biol. 73:2000;141-145
11. Miyoshi Y., Ando A., Hasegawa S., Ishitobi M., Taguchi T., Tamaki Y., Noguchi S. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin. Cancer Res. 9:2003;2288-2293
12. Selcer K.W., Jagannathan S., Rhodes M.E., Li P.K. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives. J. Steroid Biochem. Mol. Biol. 59:1996;83-91
13. Li P.K., Pillai R., Dibbelt L. Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids. 60:1995;299-306
14. Howarth N.M., Purohit A., Reed M.J., Potter B.V. Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem. 37:1994;219-221
15. Elger W., Schwarz S., Hedden A., Reddersen G., Schneider B. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J. Steroid Biochem. Mol. Biol. 55:1995;395-403
16. Purohit A., Vernon K.A., Hummelinck A.E., Woo L.W., Hejaz H.A., Potter B.V., Reed M.J. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. J. Steroid Biochem. Mol. Biol. 64:1998;269-275
17. Ciobanu L.C., Boivin R.P., Luu T.V., Labrie F., Poirier D. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17α-benzyl(or 4′-tert-butylbenzyl)estra-1, 3, 5(10)-trienes: combination of two substituents at positions C3 and C17α of estradiol. J. Med. Chem. 42:1999;2280-2286
18. Woo L.W., Howarth N.M., Purohit A., Hejaz H.A., Reed M.J., Potter B.V. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. J. Med. Chem. 41:1998;1068-1083
19. Malini B., Purohit A., Ganeshapillai D., Woo L.W., Potter B.V., Reed M.J. Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates. J. Steroid Biochem. Mol. Biol. 75:2000;253-258
20. Poirier D., Ciobanu L.C., Maltais R. Steroid sulfatase inhibitors. Exp. Opin. Ther. Patents. 9:1999;1083-1099
21. Raobaikady B., Purohit A., Chander S.K., Woo L.W., Leese M.P., Potter B.V., Reed M.J. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate. J. Steroid Biochem. Mol. Biol. 84:2003;351-358
22. Woo L.L., Purohit A., Malini B., Reed M.J., Potter B.V. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Chem. Biol. 7:2000;773-791
23. Nussbaumer P., Lehr P., Billich A. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase. J. Med. Chem. 45:2002;4310-4320
24. Ciobanu L.C., Luu-The V., Poirier D. Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors. J. Steroid Biochem. Mol. Biol. 80:2002;339-353
25. Ahmed S., James K., Owen C.P., Patel C.K. Synthesis and biochemical evaluation of novel and potent inhibitors of the enzyme oestrone sulphatase (ES). J. Steroid Biochem. Mol. Biol. 80:2002;419-427
26. Golob T., Liebl R., von Angerer E. Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells. Bioorg. Med. Chem. 10:2002;3941-3953
27. Boivin R.P., Labrie F., Poirier D. 17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity. Steroids. 64:1999;825-833
28. Boivin R.P., Luu-The V., Lachance R., Labrie F., Poirier D. Structure-activity relationships of 17α-derivatives of estradiol as inhibitors of steroid sulfatase. J. Med. Chem. 43:2000;4465-4478
29. Chu G.H., Milano S., Kluth L., Rhodes M., Boni R., Johnson D.A., Li P.K. Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors. Steroids. 62:1997;530-535
30. Kolli A., Chu G.H., Rhodes M.E., Inoue K., Selcer K.W., Li P.K. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors. J. Steroid Biochem. Mol. Biol. 68:1999;31-40
31. Wakeling A.E., Bowler J. ICI 182, 780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol. 43:1992;173-177
32. Biberger C., von Angerer E. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity. J. Steroid Biochem. Mol. Biol. 58:1996;31-43
33. von Angerer E., Prekajac J., Strohmeier J. 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. J. Med. Chem. 27:1984;1439-1447
34. Schwarz S., Thieme I., Richter M., Undeutsch B., Henkel H., Elger W. Synthesis of estrogen sulfamates: compounds with a novel endocrinological profile. Steroids. 61:1996;710-717
35. Hafner F., Holler E., von Angerer E. Effect of growth factors on estrogen mediated gene expression. J. Steroid. Biochem. Mol. Biol. 58:1996;385-393
36. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-248
37. Evans T.R., Rowlands M.G., Luqmani Y.A., Chander S.K., Coombes R.C. Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction. J. Steroid Biochem. Mol. Biol. 46:1993;195-201
38. Purohit A., de Giovani C.V., Reed M.J. The regulation of oestrone sulphate formation in breast cancer cells. J. Steroid Biochem. Mol. Biol. 68:1999;129-135
39. Jutten P., Schumann W., Hartl A., Heinisch L., Grafe U., Werner W., Ulbricht H. A novel type of nonsteroidal estrone sulfatase inhibitors. Bioorg. Med. Chem. Lett. 12:2002;1339-1342
40. Selcer K.W., Hegde P.V., Li P.K. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N- alkanoyl tyramines. Cancer Res. 57:1997;702-707
41. Hernandez-Guzman F.G., Higashiyama T., Osawa Y., Ghosh D. Purification, characterization and crystallization of human placental estrone/ dehydroepiandrosterone sulfatase, a membrane-bound enzyme of the endoplasmic reticulum. J. Steroid Biochem. Mol. Biol. 78:2001;441-450
42. Hernandez-Guzman F.G., Higashiyama T., Pangborn W., Osawa Y., Ghosh D. Structure of human estrone sulfatase suggests functional roles of membrane association. J. Biol. Chem. 278:2003;22989-22997
43. Purohit A., Williams G.J., Howarth N.M., Potter B.V., Reed M.J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry. 34:1995;11508-11514
44. Billich A., Nussbaumer P., Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J. Steroid Biochem. Mol. Biol. 73:2000;225-235
45. Purohit A., Hejaz H.A., Walden L., MacCarthy-Morrogh L., Packham G., Potter B.V., Reed M.J. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int. J. Cancer. 85:2000;584-589
46. Peters R.H., Chao W.R., Sato B., Shigeno K., Zaveri N.T., Tanabe M. Steroidal oxathiazine inhibitors of estrone sulfatase. Steroids. 68:2003;97-110
47. Birnböck H., von Angerer E. Sulfate derivatives of 2-phenylindoles as novel steroid sulfatase inhibitors: an in vitro study on structure-activity relationship. Biochem. Pharmacol. 39:1990;1709-1713